Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
1. A method for inhibiting HIV-1 replication comprising providing to a subject an anti-GBV-C E2 antibody, wherein the antibody attenuates HIV-1 infectivity.
2. The method of claim 1 , wherein the antibody is a human antibody.
3. The method of claim 1 , wherein the antibody is a monoclonal antibody.
4. The method of claim 3 , wherein the antibody is a humanized antibody.
5. The method of claim 1 , further comprising administration of at least a second anti-HIV therapy.
6. The method of claim 5 , wherein the second anti-HIV-1 therapy is HAART therapy.
7. The method of claim 5 , wherein the second anti-HIV-1 therapy is AZT therapy.
8. The method of claim 1 , wherein the antibody is provided at least twice.